TherapeuticsMD Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 1.19 M | $2.41 M | 0.00% | 10.31% |
| CLEARLINE CAPITAL LP | 05/15/2026 | 635.22 K | $1.28 M | 0.00% | 5.49% |
| 05/15/2026 | 420.42 K | $849.25 K | 100.00% | 3.63% | |
| 05/15/2026 | 353.70 K | $714.47 K | 100.00% | 3.06% | |
| TEJARA CAPITAL LTD | 05/12/2026 | 345.85 K | $698.62 K | -1.43% | 2.99% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 209.21 K | $422.60 K | 0.00% | 1.81% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 146.20 K | $295.32 K | 51.50% | 1.26% |
| MORGAN STANLEY | 05/15/2026 | 129.22 K | $261.02 K | 0.00% | 1.12% |
| BLACKROCK, INC. | 05/13/2026 | 115.15 K | $232.59 K | -0.85% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 109.82 K | $221.88 K | 3.50% | 0.95% |
| CITADEL ADVISORS LLC | 05/15/2026 | 68.31 K | $137.99 K | 141.91% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 63.83 K | $128.94 K | 100.00% | 0.55% |
| STATE STREET CORP | 05/15/2026 | 30.10 K | $60.80 K | 0.00% | 0.26% |
| XTX TOPCO LTD | 05/15/2026 | 27.49 K | $55.52 K | 100.00% | 0.24% |
| CITADEL ADVISORS LLC | 05/15/2026 | 26.80 K | $54.14 K | 30.10% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 21.22 K | $42.86 K | -39.65% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 17.00 K | $34.34 K | 0.00% | 0.15% |
| NORTHERN TRUST CORP | 05/14/2026 | 16.09 K | $32.51 K | -2.16% | 0.14% |
| JANE STREET GROUP, LLC | 05/12/2026 | 12.30 K | $24.85 K | 0.82% | 0.11% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 10.71 K | $21.63 K | 100.00% | 0.09% |
| 05/13/2026 | 9.07 K | $18.00 K | 100.00% | 0.08% | |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 4.94 K | $9.97 K | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.51 K | $3.05 K | -38.93% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 05/15/2026 | 610 | $1.23 K | 0.00% | 0.01% |
| SMARTLEAF ASSET MANAGEMENT LLC | 05/15/2026 | 601 | $1.20 K | 0.00% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 331 | $669 | -70.29% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 293 | $583 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 267 | $539 | 4.71% | 0.00% |
| US BANCORP \DE\ | 05/15/2026 | 246 | $497 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 226 | $457 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 153 | $308 | -98.35% | 0.00% |
| HUNTINGTON NATIONAL BANK | 05/15/2026 | 120 | $242 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 115 | $232 | 210.81% | 0.00% |
| FMR LLC | 05/15/2026 | 51 | $103 | -99.38% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 40 | $81 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 35 | $71 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 31 | $62 | 3.33% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 21 | $42 | 0.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 20 | $40 | 100.00% | 0.00% |
| PROVENANCE WEALTH ADVISORS, LLC | 04/20/2026 | 20 | $40 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/13/2026 | 10 | $20 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 8 | $16 | 0.00% | 0.00% |
| ASSETMARK, INC | 05/06/2026 | 4 | $8 | 0.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 05/15/2026 | 4 | $8 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 2 | $4 | -99.87% | 0.00% |
| BOGART WEALTH, LLC | 04/28/2026 | 2 | $4 | 100.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 04/22/2026 | 2 | $4 | 0.00% | 0.00% |
| JOHNSON FINANCIAL GROUP, INC. | 05/07/2026 | 1 | $3 | 100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 1 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
TherapeuticsMD Inc institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of TherapeuticsMD Inc. The most heavily invested institutionals were:
Rubric Capital Management LP: 1.19 M
Clearline Capital LP: 635,222
Tejara Capital Ltd: 345,852
ADAR1 Capital Management, LLC: 209,210
RENAISSANCE TECHNOLOGIES LLC: 146,200
MORGAN STANLEY: 129,217
33.97% of TherapeuticsMD Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.72 M shares in the last 24 months. This purchase volume represents approximately $8.56 M in transactions.